Universal Influenza Vaccine Technology Landscape
The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.
Database
Previous
Next
Preclinical
|
Phase 1
|
Phase 2
|
Phase 3
|
Approved
|
---|---|---|---|---|
Platform
Recombinant proteins |
||||
36
Vaccines in
Preclinical
|
1
Vaccines in
Phase 1
|
1
Vaccines in
Phase 2
|
1
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
Platform
Recombinant influenza virus-based |
||||
12
Vaccines in
Preclinical
|
3
Vaccines in
Phase 1
|
2
Vaccines in
Phase 2
|
0
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
Platform
Virus-vectored |
||||
20
Vaccines in
Preclinical
|
2
Vaccines in
Phase 1
|
3
Vaccines in
Phase 2
|
0
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
Platform
Virus-like particles (VLP) |
||||
24
Vaccines in
Preclinical
|
2
Vaccines in
Phase 1
|
0
Vaccines in
Phase 2
|
1
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|
|
|
|
|
Platform
Non-VLP nanoparticles |
||||
28
Vaccines in
Preclinical
|
4
Vaccines in
Phase 1
|
2
Vaccines in
Phase 2
|
1
Vaccines in
Phase 3
|
0
Vaccines in
Approved
|
|